{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T03:10:42Z","timestamp":1683256242835},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T00:00:00Z","timestamp":1129248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T00:00:00Z","timestamp":1129248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Poiesis Prax"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s10202-005-0002-3","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T10:59:08Z","timestamp":1129287548000},"page":"229-241","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk perceptions and ethical public health policy: MMR vaccination in the UK"],"prefix":"10.1007","volume":"3","author":[{"given":"Angus","family":"Dawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,14]]},"reference":[{"issue":"6","key":"2_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1467-8519.2004.00412.x","volume":"18","author":"R Bayer","year":"2004","unstructured":"Bayer R, Fairchild A (2004) The genesis of public health ethics. Bioethics 18(6):473\u2013492","journal-title":"Bioethics"},{"issue":"1","key":"2_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1088-4963.1995.tb00020.x","volume":"24","author":"G Cullity","year":"1995","unstructured":"Cullity G (1995) Moral free riding. Philos Public Aff 24(1):3\u201334","journal-title":"Philos Public Aff"},{"key":"2_CR3","volume-title":"Engaging the world: the use of empirical research in bioethics and the regulation of biotechnology","author":"A Dawson","year":"2004","unstructured":"Dawson A (2004) What should we do about it? implications of the empirical evidence in relation to comprehension and acceptability of randomisation. In: Holm S, Jonas M (eds) Engaging the world: the use of empirical research in bioethics and the regulation of biotechnology. IOS Press, Netherlands"},{"issue":"2","key":"2_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1467-8519.2005.00433.x","volume":"19","author":"A Dawson","year":"2005","unstructured":"Dawson A (2005a) The determination of \u201cBest Interests\u201d in relation to childhood vaccinations. Bioethics 19(2):188\u2013205","journal-title":"Bioethics"},{"key":"2_CR5","volume-title":"Ethics, prevention and public health","author":"A Dawson","year":"2005","unstructured":"Dawson A (2005b) Herd protection as a public good: vaccination and our obligations to others. In: Dawson A, Verweij M (eds) Ethics, prevention and public health. Oxford University Press, Oxford (in press)"},{"key":"2_CR6","volume-title":"Communicating about risks to public health","author":"Department of Health","year":"1998","unstructured":"Department of Health (1998) Communicating about risks to public health. Department of Health, London"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/bmj.322.7280.183","volume":"322","author":"D Elliman","year":"2001","unstructured":"Elliman D, Bedford H (2001) MMR vaccine: the continuing saga. BMJ 322:183\u2013184","journal-title":"BMJ"},{"key":"2_CR8","doi-asserted-by":"crossref","unstructured":"Garrard E, Dawson A (2005) What is the role of the REC? paternalism, inducements and harm in research ethics. J Med Ethics (in press)","DOI":"10.1136\/jme.2004.010447"},{"key":"2_CR9","volume-title":"Towards a better map: science, the public and the media","author":"I Hargreaves","year":"2003","unstructured":"Hargreaves I, Lewis J, Speers T (2003) Towards a better map: science, the public and the media. ESRC, Swindon"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/bmj.323.7317.838","volume":"323","author":"T Heller","year":"2001","unstructured":"Heller T (2001) Ethical debate: vaccination against mumps, measles,& rubella: is there a case for deepening the debate? BMJ 323:838\u2013840","journal-title":"BMJ"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/bmj.324.7339.733","volume":"324","author":"M Jarmulowicz","year":"2002","unstructured":"Jarmulowicz M (2002) Single measles vaccine should be allowed. BMJ 324:733","journal-title":"BMJ"},{"issue":"3","key":"2_CR12","first-page":"241","volume":"16","author":"G Klosko","year":"1987","unstructured":"Klosko G (1987) Presumptive benefit, fairness and political obligation. Philos Public Aff 16(3):241\u2013259","journal-title":"Philos Public Aff"},{"issue":"19","key":"2_CR13","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa021134","volume":"347","author":"K Madsen","year":"2002","unstructured":"Madsen K et\u00a0al (2002) A population-based study of measles, mumps and rubella vaccination and autism. NEJM 347(19):1477\u20131482","journal-title":"NEJM"},{"key":"2_CR14","unstructured":"NHS (2003\u20132004) NHS immunisation statistics, England. Bulletin 2004\/16, London"},{"issue":"12","key":"2_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/00006454-200012000-00002","volume":"19","author":"A Patja","year":"2000","unstructured":"Patja A et\u00a0al (2000) Serious adverse events after measles\u2013mumps\u2013rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 19(12):1127\u20131134","journal-title":"Pediatr Infect Dis J"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.vaccine.2003.07.016","volume":"22","author":"Y Paul","year":"2004","unstructured":"Paul Y (2004) Letter: herd immunity and herd protection. Vaccine 22:301\u2013302","journal-title":"Vaccine"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","volume":"1","author":"H Peltola","year":"1986","unstructured":"Peltola H, Heinonen O (1986) Frequency of true adverse reactions in measles\u2013mumps\u2013rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1:939\u2013942","journal-title":"Lancet"},{"key":"2_CR18","doi-asserted-by":"crossref","DOI":"10.4159\/9780674042605","volume-title":"A theory of justice","author":"J Rawls","year":"1971","unstructured":"Rawls J (1971) A theory of justice. Oxford University Press, Oxford"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0140-6736(04)17020-7","volume":"364","author":"L Smeeth","year":"2004","unstructured":"Smeeth L et\u00a0al (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364:963\u2013969","journal-title":"Lancet"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.7455683","volume":"211","author":"A Tversky","year":"1981","unstructured":"Tversky A, Kahneman D (1981) The framing of decisions and the psychology of choice. Science 211:453\u2013458","journal-title":"Science"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1037\/0003-066X.39.4.341","volume":"39","author":"A Tversky","year":"1984","unstructured":"Tversky A, Kahneman D (1984) Choices, values and frames. Am Psychol 39:341\u2013350","journal-title":"Am Psychol"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.vaccine.2004.01.062","volume":"22","author":"M Verweij","year":"2004","unstructured":"Verweij M, Dawson A (2004) Ethical principles for collective immunisation programmes. Vaccine 22:3122\u20133126","journal-title":"Vaccine"},{"key":"2_CR23","unstructured":"Verweij M, Dawson A (2005) What is meant by \u201cpublic\u201d in public health? In: Dawson A, Verweij M (eds) Ethics, prevention and public health. Oxford University Press, Oxford (in press)"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"A Wakefield","year":"1998","unstructured":"Wakefield A et\u00a0al (1998) Ileal\u2013lymphoid\u2013nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 351:637\u2013641","journal-title":"Lancet"},{"issue":"4","key":"2_CR25","first-page":"265","volume":"19","author":"A Wakefield","year":"2000","unstructured":"Wakefield A, Montgomery S (2000) Measles, mumps and rubella vaccine: through a glass, darkly. Adverse drug react. Toxicol Rev 19(4):265\u2013283","journal-title":"Adverse drug react. Toxicol Rev"}],"container-title":["Poiesis & Praxis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10202-005-0002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10202-005-0002-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10202-005-0002-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10202-005-0002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:45:59Z","timestamp":1683254759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10202-005-0002-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,14]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s10202-005-0002-3","relation":{},"ISSN":["1615-6609","1615-6617"],"issn-type":[{"value":"1615-6609","type":"print"},{"value":"1615-6617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,14]]},"assertion":[{"value":"14 October 2005","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}